Sara Mangsbo is this week's guest in Hälso- och sjukvårdspodden

In this week's episode of the Hälso- och sjukvårdspodden, Magnus Lejelöv, host and Pharma Profile of the Year 2019, and Sara Mangsbo, Professor of Protein and Antibody Drugs, team up for a conversation highligting research, innovation, inspiration and – not least – Uppsala. Listen NOW at healthpolicy.se/podden and other podcast platforms.
Forum for Health Policy celebrates episode 143 of Hälso- och sjukvårdspodden by inviting Professor and Uppsala resident Sara Mangsbo – a household name among everyone with an interest in immunology and entrepreneurship. Together with podcast host Magnus Lejelöv, also Head of Sales at Pelago Bioscience, Sara start out presenting her hopes for Swedish Healthcare 2040:
“Today, there is so much going on in the fields of innovation that can improve healthcare, and in 2040 I wish that we will have developed methods to coordinate and simplify the implementation of digital tools. Today, there is a certain amount of frustration about digitalisation complicating things more than it provides. We have to change this perception in order for future innovations to contribute the greatest value possible for both employees and patients."
The conversation also focus on research, driving forces, awards and reason on innovation and teacher intake and a number of other relevant aspects of the system. Listen now to the podcast episode at healthpolicy.se/podden and other well-sorted podcast platforms.
In fact
- Hälso- och sjukvårdspodden is a podcast about life, health and politics produced by the Forum for Health Policy think tank.
- Sara Mangsbo is a Professor of Protein and Antibody Drugs at the Department of Pharmacy, has been named Entrepreneur of the Year, won the Uppsala University innovation award and earned a place on IVA's 100 list of Sweden's hottest research projects with her acclaimed method Adaptable Drug Affinity Conjugate.
Kontact
Sara Mangsbo, Professor
Department of Pharmacy
Sara.Mangsbo@farmbio.uu.se
Text: Magnus Alsne, photo: Mikael Wallerstedt a o